Menu

Genetic Clues in the Newtown Massacre

Investigators are calling on scientists to comb Adam Lanza’s DNA for potential drivers of his violent behavior last week in Connecticut.

Dec 20, 2012
Bob Grant

Police at Sand Hook Elementry, after the shooting on December 14, 2012.WIKIMEDIA< VOAOfficials in Connecticut are searching for any clues that may help them piece together the motivations of Adam Lanza, the 20-year-old man who killed his mother before going on a deadly shooting spree in an elementary school last Friday (December 14), gunning down 20 young children, and 6 other adults in the idyllic New England town of Newtown. According to The Hartford Courant, H. Wayne Carver, Connecticut’s chief medical examiner, has invited a University of Connecticut geneticist to join him in the investigation of the killings. “I’m exploring with the department of genetics what might be possible, if anything is possible,” Carver told the Courant on Tuesday. “Is there any identifiable disease associated with this behavior?”

Some sources have averred that Lanza had Asperger’s syndrome, an autism spectrum disorder, but that has yet to be definitively determined. Carver told the Courant that he is still awaiting toxicology reports that may further expose biological clues to Lanza’s violent act.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.